Perioperative stress responses are complex physiological reactions to surgical trauma, anesthesia, and environmental factors, impacting postoperative outcomes considerably. Recent literature underscores the significance of tailoring perioperative preparation based on the patient's individual risk profile to attenuate adverse stress responses, reduce complications, and optimize recovery. This review synthesizes current evidence on individualized perioperative stress-response strategies, explores underlying mechanisms, discusses clinical implications, and provides guideline-based recommendations for implementation in surgical practice.
The perioperative period is characterized by a cascade of neuroendocrine, metabolic, and immunological responses to surgical insult, collectively termed the stress response. While these physiological changes are adaptive, excessive or prolonged stress responses have been linked to increased morbidity and delayed recovery. Personalized perioperative preparation incorporating patient-specific factors and targeted interventions has emerged as a promising paradigm to enhance surgical outcomes. This article reviews the epidemiology, pathophysiology, and clinical relevance of perioperative stress, and evaluates evidence-based strategies for individualized prevention and management.
Globally, an estimated 310 million surgeries are performed annually, with perioperative complications accounting for significant morbidity, prolonged hospitalization, and healthcare expenditures. The burden is particularly high in older adults and patients with comorbidities, where exaggerated stress responses correlate with adverse cardiac, pulmonary, and infectious outcomes. Hospital-acquired complications following major surgery often stem from unmitigated stress responses, emphasizing the need for proactive prevention strategies. Recent data suggest that up to 30% of postoperative complications may be preventable through optimized perioperative care, including stress-response modulation.
The perioperative stress response is mediated primarily by activation of the hypothalamic-pituitary-adrenal (HPA) axis and sympathetic nervous system. Surgical trauma initiates nociceptive signaling, leading to the release of corticotropin-releasing hormone, adrenocorticotropic hormone, cortisol, catecholamines, and inflammatory cytokines. The resultant physiological changes include tachycardia, hypertension, hyperglycemia, immunosuppression, and catabolism. While acute stress is necessary for survival, excessive or sustained activation disrupts homeostasis, impairs wound healing, and predisposes to infection, cardiovascular events, and organ dysfunction. The magnitude of the response varies with patient age, comorbidities, psychological state, surgical type, and anesthetic technique.
Key risk factors for adverse perioperative stress responses include advanced age, frailty, preexisting cardiovascular or metabolic disease, obesity, chronic pain, psychological distress, and previous poor surgical outcomes. Patients with diabetes, chronic kidney disease, or immunosuppression are especially vulnerable. Additionally, high-risk surgeries such as cardiac, major abdominal, or oncological procedures carry a greater physiological burden. Preoperative factors such as malnutrition, sleep deprivation, anxiety, and untreated pain can further amplify stress responses. Accurate risk stratification using validated tools (e.g., ASA Physical Status, Revised Cardiac Risk Index) is crucial for individualized perioperative planning.
Clinically, perioperative stress manifests as hemodynamic instability, arrhythmias, hyperglycemia, confusion or delirium, impaired immune function, and delayed wound healing. In the immediate postoperative period, patients may exhibit tachycardia, hypertension, diaphoresis, and elevated cortisol or glucose levels. In some, excessive stress responses precipitate myocardial infarction, stroke, or sepsis. Psychological features, such as perioperative anxiety, can exacerbate physiological responses and increase analgesic requirements. Recognition of these features enables timely intervention and mitigates complications.
Diagnosis of excessive perioperative stress is primarily clinical, supported by laboratory findings such as elevated serum cortisol, catecholamines, inflammatory markers (e.g., C-reactive protein, interleukin-6), and hyperglycemia. Validated assessment tools may include perioperative risk calculators, stress and anxiety scales, and frailty indices. Continuous hemodynamic monitoring and point-of-care glucose measurement are essential for high-risk patients. Multimodal assessment combining physiological, biochemical, and psychological indicators provides a comprehensive view of patient status and guides individualized interventions.
Preventive and therapeutic strategies for perioperative stress response focus on individualized risk reduction and modulation of pathophysiological mechanisms. Core elements include prehabilitation (nutritional optimization, exercise, psychological support), patient education, and preoperative anxiolysis. Intraoperatively, regional anesthesia, multimodal analgesia, goal-directed fluid therapy, and minimally invasive surgical techniques are recommended to reduce nociceptive input and neuroendocrine activation. Enhanced Recovery After Surgery (ERAS) protocols, which integrate evidence-based interventions across the perioperative continuum, have demonstrated reduced complications and length of stay. Postoperatively, early mobilization, glycemic control, and ongoing pain management are critical for attenuating sustained stress responses. Individualized plans should be tailored based on patient risk profile and surgical complexity.
Recent advances in perioperative medicine highlight the role of personalized medicine, including genetic and biomarker profiling to predict stress responsiveness. Novel anesthetic agents with immunomodulatory properties, pharmacological modulation of the HPA axis, and targeted anti-inflammatory therapies are under investigation. Digital health platforms now facilitate remote prehabilitation, patient monitoring, and early detection of stress-related complications. Integrative approaches such as mindfulness, cognitive-behavioral therapy, and virtual reality are being studied for preoperative anxiety reduction. Emerging evidence supports the role of perioperative beta-blockers, statins, and glucocorticoid-sparing regimens in select high-risk populations.
International guidelines from the American Society of Anesthesiologists (ASA), European Society of Anaesthesiology, and ERAS Society advocate for risk-stratified, patient-centered perioperative care. Key recommendations include thorough preoperative assessment, implementation of ERAS pathways, use of regional anesthesia where feasible, and multidisciplinary collaboration. Guidelines emphasize the importance of shared decision-making, individualized analgesia plans, glycemic control, and early mobilization. For high-risk patients, preoperative optimization and close postoperative surveillance are prioritized. Adherence to guideline-based protocols has been shown to reduce perioperative stress responses and improve outcomes in diverse surgical populations.
Individualized perioperative stress-response preparation is a cornerstone of modern surgical care, offering substantial benefits in reducing complications and enhancing recovery. Integration of risk assessment tools, personalized interventions, and guideline-based protocols enables clinicians to modulate physiological stress responses effectively. Ongoing research into novel therapies and digital health solutions promises to further refine individualized perioperative management. By embracing a patient-centered, evidence-based approach, healthcare teams can optimize outcomes and advance the quality of surgical care.
1.
"Unusual" Cancers Following Pandemic; Triumph in TNBC; Clinical Trial Interrupted by Shortage.
2.
Recently released national data on drug use and abuse among Americans.
3.
Despite Medicare Coverage, Cancer Genomic Testing Still Low
4.
Ketamine plus psychotherapy for "excellent" PTSD
5.
Psychedelic Therapy Tied to Reduced Depression, Anxiety.
1.
Personalized Tumor Ecological Landscapes in Oncology
2.
Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer
3.
Preserving Social Identity During Cancer Survivorship
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Regenerative Models of Tumor Microenvironments: Clinical Relevance and Emerging Insights
1.
International Conference on Cancer Nursing and Rehabilitation Strategies
2.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
3.
International Conference on Innovations in Critical Care for Oncology and Cardiology
4.
International Symposium on Oncology, Cardiology and Critical Care Innovations
5.
International Conference on Cancer Nursing and Hematology Support
1.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
4.
From Guidelines to Practice: Hematology
5.
Breast Cancer Awareness and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation